Unraveling the Immunopathological Landscape of Celiac Disease: A Comprehensive Review
Open Access
- 23 October 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (20) , 15482
Abstract
Celiac disease (CD) presents a complex interplay of both innate and adaptive immune responses that drive a variety of pathological manifestations. Recent studies highlight the role of immune-mediated pathogenesis, pinpointing the involvement of antibodies against tissue transglutaminases (TG2, TG3, TG6), specific HLA molecules (DQ2/8), and the regulatory role of interleukin-15, among other cellular and molecular pathways. These aspects illuminate the systemic nature of CD, reflecting its wide-reaching impact that extends beyond gastrointestinal symptoms to affect other physiological systems and giving rise to a range of pathological landscapes, including refractory CD (RCD) and, in severe cases, enteropathy-associated T cell lymphoma. The existing primary therapeutic strategy, a gluten-free diet (GFD), poses significant challenges, such as low adherence rates, necessitating alternative treatments. Emerging therapies target various stages of the disease pathology, from preventing immunogenic gluten peptide absorption to enhancing intestinal epithelial integrity and modulating the immune response, heralding potential breakthroughs in CD management. As the understanding of CD deepens, novel therapeutic avenues are emerging, paving the way for more effective and sophisticated treatment strategies with the aim of enhancing the quality of life of CD patients. This review aims to delineate the immunopathology of CD and exploring its implications on other systems, its complications and the development of novel treatments.Keywords
This publication has 115 references indexed in Scilit:
- Risk of Idiopathic Dilated Cardiomyopathy in 29 000 Patients With Celiac DiseaseJournal of the American Heart Association, 2012
- The Oslo definitions for coeliac disease and related termsGut, 2012
- Celiac disease and transglutaminase 2: a model for posttranslational modification of antigens and HLA association in the pathogenesis of autoimmune disordersCurrent Opinion in Immunology, 2011
- Single-chain recombinant HLA-DQ2.5/peptide molecules block α2-gliadin-specific pathogenic CD4+ T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac diseaseMucosal Immunology, 2010
- Celiac Disease Diagnosis: Simple Rules Are Better Than Complicated AlgorithmsThe American Journal of Medicine, 2010
- IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease–associated inflammation and lymphomagenesisJournal of Clinical Investigation, 2010
- Classification and management of refractory coeliac diseaseGut, 2010
- Systematic review: adherence to a gluten‐free diet in adult patients with coeliac diseaseAlimentary Pharmacology & Therapeutics, 2009
- Cyclic and dimeric gluten peptide analogues inhibiting DQ2-mediated antigen presentation in celiac diseaseBioorganic & Medicinal Chemistry, 2007
- Reprogramming of CTLs into natural killer–like cells in celiac diseaseJournal of Experimental Medicine, 2006